Synthesis and characterization of a selective peptide antagonist of neuropeptide Y vascular postsynaptic receptors

British Journal of Pharmacology

Volumn 117, Issue 8, 1996, Pages 1768-1772

  Lew, Michael J ^a   Murphy, Roger ^a   Angus, James A ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Mesenteric artery; Neuropeptide y antagonist; Vas deferens

Indexed keywords

GR 231118; NEUROPEPTIDE Y RECEPTOR; NEUROPEPTIDE Y RECEPTOR ANTAGONIST; NEUROPEPTIDE Y [13-36]; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; MALE; MESENTERIC ARTERY; MOUSE; MUSCLE TWITCH; NONHUMAN; PRIORITY JOURNAL; RAT; SYMPATHETIC NERVE; VAS DEFERENS;

EID: 0029916346     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15352.x     Document Type: Article

References (27)

1. 1-adrenoceptor stimulation in rat isolated mesenteric arterioles. Br. J. Pharmacol., 99, 389-395.
2. ARIËNS, E.J., ROSSUM, J.M.V. & KOOPMAN, P.C. (1960). Receptor reserve and threshold phenomena I. Theory and experiments with autonomic drugs tested on isolated organs. Arch. Int. Pharmacodyn., 127, 459-478.
3. DANIELS, A.J., HEYER, D., LANDVAZO, O., LEBAN, J.K. & SPALTENSTEIN, A. (1994). Neuropeptide Y antagonists. Patent Number WO 94/00486.
4. DANIELS, A.J., MATTHEWS, J.E., SLEPETIS, R.J., JANSEN, M., VIVEROS, O.H., TADEPALLI, A., HARRINGTON, W., HEYER, D., LANDAVAZO, A., LEBAN, J.J. & SPALTENSTEIN, A. (1995). Novel high-affinity neuropeptide Y receptor antagonists. Proc. Natl. Acad. Sci. U.S.A., 92 9067-9071.
5. DOUGHTY, M.B., CHU, S.S., MILLER, D.W., LI, K. & TESSEL, R.E. (1990). Benextramine: a long-lasting neuropeptide Y receptor antagonist. Eur. J. Pharmacol., 185, 113-115.
6. EDVINSSON, J., EKBLAD, E., HAKANSON, R. & WAHLESEDT, C. (1984). Neuropeptide Y potentiates effect of various constrictor agents on rabbit blood vessels. Br. J. Pharmacol., 83, 519-525.
7. FREDHOLM, B.B., JANSEN, I. & EDVINSSON, L. (1985). Neuropeptide Y is a potent inhibitor of cyclic AMP accumulation in feline cerebral blood vessels. Acta Physiol. Scand., 124, 467-469.
8. GUSTAFFSON, H. & NILSSON, H. (1990). Endothelium-independent potentiation by neuropeptide Y of vasoconstrictor responses in isolated arteries from rat and rabbit. Acta Physiol. Scand., 138, 503-507.
9. KENAKIN, T.P., BOND, R.A. & BONNER, T.I. (1992). Definition of pharmacological receptors. Pharmacol. Rev., 44, 351-362.
10. LAHER, I., GERMANN, P. & BEVAN, J.A. (1994). Neurogenically evoked cerebral artery constriction is mediated by neuropeptide Y. Can. J. Physiol. Pharmacol., 72, 1086-1088.
11. LEW, M.J. & ANGUS, J.A. (1984). Reversible inhibition of neuronal uptake by benextramine, an irreversible presynaptic alpha-adrenoceptor antagonist. Eur. J. Pharmacol., 98, 27-34.
12. LEW, M.J. & ANGUS, J.A. (1995). An improved method for analysis of competitive agonist-antagonist interactions by non-linear regression. Trends. Pharmacol. Sci., 16, 328-337.
13. LOBAUGH, L.A. & BLACKSHEAR, P.J. (1990). NPY binding and inhibition of cAMP accumulation in human neuroepithelioma cells. Am. J. Physiol., 258, C913.
14. LUNDBERG, J.M., PERNOW, J., DAHLÖF, C. & TATEMOTO, K. (1985). Pre- and postjunctional effects of NPY in the rat femoral artery. Acta Physiol. Scand., 123, 511-513.
15. MELCHIORRE, C., ROMUAULDI, P., BOLOGNESI, M.L., DONATINI, A. & FERRI, S. (1994). Binding profile of benextramine at neuropeptide Y receptor subtypes in rat brain areas. Eur. J. Pharmacol., 265, 93-98.
16. NEILD, T.O. (1989). Measurement of arteriole diameter changes by analysis of television images. Blood Vess., 26, 48-52.
17. 2+-dependent contraction by neuropeptide Y in rabbit mesenteric arteries. Gen. Pharmacol., 20, 363-367.
18. PLOTEK, Y. & ATLAS, D. (1983). Characterization of benextramine as an irreversible α-adrenergic blocker and as a blocker of potassium-activated calcium channels. Eur. J. Biochem., 133, 539-544.
19. 1 receptor antagonist: BIBP3226. Eur. J. Pharmacol., 271, R11-R13.
20. SAVILLE, V.L., MAYNARD, K.L. & BURNSTOCK, G. (1990). Neuropeptide Y potentiates purinergic as well as adrenergic responses of the rabbit ear artery. Eur. J. Pharmacol., 176, 117-125.
21. STUPECKY, G.L., MURRAY, D.L. & PURDY, R.E. (1986). Vasoconstrictor threshold synergism and potentiation in the rabbit isolated thoracic aorta. J. Pharmacol. Exp. Ther., 238, 802-808.
22. TATEMOTO, K. (1990). Neuropeptide Y and its receptor antagonists. Ann. N.Y. Acad. Sci., 611, 1-6.
23. 2 receptors: evidence from benextramine protection studies J. Pharmacol. Exp. Ther., 265, 172-177.
24. WAHLESTEDT, C. & REIS, D.J. (1993). Neuropeptide Y-related peptides and their receptors: are the receptors potential therapeutic drug targets? Ann. Rev. Pharmacol. Toxicol., 32, 309-351.
25. WAHLESTEDT, C., REIS, D.J., YOO, H., ANDERSSON, D. & EDVINSSON, L. (1992). A novel inositol phosphate selectively inhibits vasoconstriction evoked by the sympathetic co-transmitters neuropeptide Y (NPY) and adenosine trisphosphate (ATP). Neurosci. Lett., 143, 123-126.
26. XIONG, Z., BOLZON, B.J. & CHEUNG, D.W. (1993). Neuropeptide Y potentiates calcium-channel currents in single vascular smooth muscle cells. Pfluegers Arch., 423, 504-510.
27. + channels in vascular smooth muscle cells from the rat tail artery. Pfluegers Arch., 429, 280-284.